VIRTUAL: Adeno-associated Virus Gene Therapy for Hereditary Neurologic Disorders
Time: 8:15 am
day: Day One
- Exploring the vectors used to target hereditary neurologic disorders
- Assessing the delivery methods and challenges for AAV; where does my vector go?
- Evaluating gene therapy for CLN2 disease and APOE4 Alzheimer’s disease